Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Yuanhua Biotechnology is a specialized pharmaceutical company headquartered in Tianmen, Hubei Province, China, focusing on the development and manufacture of steroid hormone APIs and intermediates. The company integrates advanced biotechnological fermentation with traditional chemical synthesis to produce high-purity steroids, including progesterone, testosterone, and various corticosteroids. Hubei Yuanhua serves as a critical supplier in the global pharmaceutical supply chain, providing essential building blocks for medications used in reproductive health, endocrinology, and inflammatory conditions. Their operations are characterized by a commitment to green manufacturing processes and large-scale production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Yuanhua Biotechnology.